EP1390091B1 — Inhaler
Assigned to Innovata Biomed Ltd · Expires 2009-01-14 · 17y expired
What this patent protects
There is described an air amplifying system comprising an amplifying fluid jet provided with a fluid inlet and a fluid outlet, the fluid outlet being linked to an outlet nozzle via an amplifying passage, the amplifying passage also being linked to a powder chamber, said chamber b…
USPTO Abstract
There is described an air amplifying system comprising an amplifying fluid jet provided with a fluid inlet and a fluid outlet, the fluid outlet being linked to an outlet nozzle via an amplifying passage, the amplifying passage also being linked to a powder chamber, said chamber being adapted for non-laminar powder flow, such that fluid travelling from the fluid outlet of the jet draws extraneous air and aerosolised powder through the powder chamber so that the extraneous air and aerosolised powder mix with the amplifying fluid in the amplifying passage and the amplified mixture exits through the outlet nozzle. There is also described a powder delivery device comprising such an air amplifying system and a method of treatment related thereto.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.